HIV/AIDS
New findings from the United States, Canada and South Africa in the area of HIV/AIDS detailed
Published in AIDS Weekly, August 28th, 2006
Study 1: Nevirapine resistance decreases survival time associated with nevirapine-based antiretroviral therapy.
"Nevirapine (NVP) resistance may decrease the effectiveness of viral suppression with NVP-based antiretroviral therapy (ART) in women infected with human immunodeficiency virus (HIV) with previous exposure to single-dose NVP. However, the alternative lopinavir-ritonavir-based ART regimen is more expensive," researchers in the United States report.
According to C.B. Holmes and colleagues at Massachusetts General Hospital in Boston,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-08-28)
More Articles from AIDS Weekly
- DNA Research
HIV-1 Tat depresses DNA-PK(CS) expression and DNA repair - HIV/AIDS Pathogenesis
Genetic variation in chemokine gene cluster influences HIV-1 transmission and progression - HIV/AIDS Pathogenesis
Residual HIV-1 viremia dominated by small number of viral clones without evident evolution - HIV/AIDS Therapy
Cyclosporin A inhibits HIV-1 infection at both early and late phases of virus replication - Antimicrobials
New company to market microbicide by 2010; Tommy Thompson chairs Instead Sciences - Aspergillus Endophthalmitis Treatment
Intravitreal voriconazole successfully treats Aspergillus endophthalmitis infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
